IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN
Previous studies reported some associations between class A antibodies specific for benzo[a]pyrene (IgA-Bp), estradiol (IgA-Es) and progesterone (IgA-Pg) and breast cancer (BC) in women like as with lung cancer (LC) in men. It was suggested that IgA-Bp and IgA-Es may stimulate tumor initiation and p...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
SPb RAACI
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/03459d37357d4e0285d4141d1617687e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:03459d37357d4e0285d4141d1617687e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:03459d37357d4e0285d4141d1617687e2021-11-18T08:03:47ZIMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN1563-06252313-741X10.15789/1563-0625-2018-6-927-934https://doaj.org/article/03459d37357d4e0285d4141d1617687e2018-12-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1681https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XPrevious studies reported some associations between class A antibodies specific for benzo[a]pyrene (IgA-Bp), estradiol (IgA-Es) and progesterone (IgA-Pg) and breast cancer (BC) in women like as with lung cancer (LC) in men. It was suggested that IgA-Bp and IgA-Es may stimulate tumor initiation and promotion, whereas IgA-Pg may inhibit the in vivo human carcinogenesis.The purpose of this study was to identify the suggested associations of such immunological imbalance with BC and LC in postmenopausal women.The serum A-class antibodies specific to benzo[a]pyrene, estradiol and progesterone (IgA-Bp, IgA-Es, IgA- Pg) were studied in 335 healthy women, 824 breast cancer (BC) patients and 127 cases of lung cancer (LC) by means of non-competitive solid phase immunoassay. The following results were obtained: Increased ratio of IgA-Bp and IgA-Es amounts exceeding the IgA-Pg levels was associated with a higher risk of breast cancer (OR = 2.8 and 2.4 respectively, p < 0.0001), and higher risk of LC (OR = 2.9 and 2.8, respectively, p < 0.0001). Conversely, the OR values decreased to 0.3-0.4 for BC and LC if IgA-Pg levels were higher than IgA-Bp and IgA-Es levels (p < 0.0001). These findings confirm the hypothesis that IgA-Bp and IgA-Es are capable to stimulate, and IgA-Pg, to inhibit the BC and LC occurrence n postmenopausal women. The balance between IgA-Bp and IgA-Es, on the one hand, and IgA-Pg, on the other hand, is much more important than individual contents of these antibodies.In conclusion, the phenomenon of “immunological interference” is revealed, i.e., the mutual enhancement of IgA-Bp and IgA-Es effects, thus, probably, stimulating the initial and subsequent events of carcinogenesis initiation and promotion, with a weak anticancer effect of IgA-Pg, and by weakening the mutual procarcinogenic effects of IgA-Bp and IgA-Es by the marked effect of IgA-Pg.A. N. GlushkovE. G. PolenokL. A. GordeevaS. A. MunM. V. KostyankoA. V. AntonovV. A. TitovN. E. VerzhbitskayaI. A. VafinSPb RAACIarticlebreast cancerlung cancerantibodiesbenzo[a]pyreneestradiolprogesteronecarcinogenesisImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 20, Iss 6, Pp 927-934 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
RU |
| topic |
breast cancer lung cancer antibodies benzo[a]pyrene estradiol progesterone carcinogenesis Immunologic diseases. Allergy RC581-607 |
| spellingShingle |
breast cancer lung cancer antibodies benzo[a]pyrene estradiol progesterone carcinogenesis Immunologic diseases. Allergy RC581-607 A. N. Glushkov E. G. Polenok L. A. Gordeeva S. A. Mun M. V. Kostyanko A. V. Antonov V. A. Titov N. E. Verzhbitskaya I. A. Vafin IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| description |
Previous studies reported some associations between class A antibodies specific for benzo[a]pyrene (IgA-Bp), estradiol (IgA-Es) and progesterone (IgA-Pg) and breast cancer (BC) in women like as with lung cancer (LC) in men. It was suggested that IgA-Bp and IgA-Es may stimulate tumor initiation and promotion, whereas IgA-Pg may inhibit the in vivo human carcinogenesis.The purpose of this study was to identify the suggested associations of such immunological imbalance with BC and LC in postmenopausal women.The serum A-class antibodies specific to benzo[a]pyrene, estradiol and progesterone (IgA-Bp, IgA-Es, IgA- Pg) were studied in 335 healthy women, 824 breast cancer (BC) patients and 127 cases of lung cancer (LC) by means of non-competitive solid phase immunoassay. The following results were obtained: Increased ratio of IgA-Bp and IgA-Es amounts exceeding the IgA-Pg levels was associated with a higher risk of breast cancer (OR = 2.8 and 2.4 respectively, p < 0.0001), and higher risk of LC (OR = 2.9 and 2.8, respectively, p < 0.0001). Conversely, the OR values decreased to 0.3-0.4 for BC and LC if IgA-Pg levels were higher than IgA-Bp and IgA-Es levels (p < 0.0001). These findings confirm the hypothesis that IgA-Bp and IgA-Es are capable to stimulate, and IgA-Pg, to inhibit the BC and LC occurrence n postmenopausal women. The balance between IgA-Bp and IgA-Es, on the one hand, and IgA-Pg, on the other hand, is much more important than individual contents of these antibodies.In conclusion, the phenomenon of “immunological interference” is revealed, i.e., the mutual enhancement of IgA-Bp and IgA-Es effects, thus, probably, stimulating the initial and subsequent events of carcinogenesis initiation and promotion, with a weak anticancer effect of IgA-Pg, and by weakening the mutual procarcinogenic effects of IgA-Bp and IgA-Es by the marked effect of IgA-Pg. |
| format |
article |
| author |
A. N. Glushkov E. G. Polenok L. A. Gordeeva S. A. Mun M. V. Kostyanko A. V. Antonov V. A. Titov N. E. Verzhbitskaya I. A. Vafin |
| author_facet |
A. N. Glushkov E. G. Polenok L. A. Gordeeva S. A. Mun M. V. Kostyanko A. V. Antonov V. A. Titov N. E. Verzhbitskaya I. A. Vafin |
| author_sort |
A. N. Glushkov |
| title |
IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| title_short |
IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| title_full |
IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| title_fullStr |
IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| title_full_unstemmed |
IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN |
| title_sort |
immunological imbalance in breast cancer and lung cancer in postmenopausal women |
| publisher |
SPb RAACI |
| publishDate |
2018 |
| url |
https://doaj.org/article/03459d37357d4e0285d4141d1617687e |
| work_keys_str_mv |
AT anglushkov immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT egpolenok immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT lagordeeva immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT samun immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT mvkostyanko immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT avantonov immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT vatitov immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT neverzhbitskaya immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen AT iavafin immunologicalimbalanceinbreastcancerandlungcancerinpostmenopausalwomen |
| _version_ |
1718422331354775552 |